Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

New AI tool brings precision pathology for cancer and beyond into quicker, sharper focus

New AI tool brings precision pathology for cancer and beyond into quicker, sharper focus

Analysing how cancer mutations interact may improve targeted therapies

Analysing how cancer mutations interact may improve targeted therapies

FDA approves belzutifan for advanced renal cell carcinoma

FDA approves belzutifan for advanced renal cell carcinoma

Researchers uncover on/off switch for breast cancer metastasis

Researchers uncover on/off switch for breast cancer metastasis

FDA approves eflornithine for adult and paediatric patients with high-risk neuroblastoma

FDA approves eflornithine for adult and paediatric patients with high-risk neuroblastoma

ASH 2023: Study shows CAR-T cell therapy safe, effective even for high-risk patients

ASH 2023: Study shows CAR-T cell therapy safe, effective even for high-risk patients

ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia

ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia

ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk...

ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib

ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment...

ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments

ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments

More from ecancer